NO780984L - Fremgangsmaate ved fremstilling av nye 9-fluorprednisoloner - Google Patents

Fremgangsmaate ved fremstilling av nye 9-fluorprednisoloner

Info

Publication number
NO780984L
NO780984L NO780984A NO780984A NO780984L NO 780984 L NO780984 L NO 780984L NO 780984 A NO780984 A NO 780984A NO 780984 A NO780984 A NO 780984A NO 780984 L NO780984 L NO 780984L
Authority
NO
Norway
Prior art keywords
solons
predision
fluoro
procedures
preparation
Prior art date
Application number
NO780984A
Other languages
English (en)
Other versions
NO151043C (no
NO151043B (no
Inventor
Klaus Annen
Henry Laurent
Helmut Hofmeister
Rudolf Wiechert
Hans Wendt
Joachim-Friedrich Kapp
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2712862A external-priority patent/DE2712862C2/de
Priority claimed from DE19782809732 external-priority patent/DE2809732C2/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO780984L publication Critical patent/NO780984L/no
Publication of NO151043B publication Critical patent/NO151043B/no
Publication of NO151043C publication Critical patent/NO151043C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO780984A 1977-03-21 1978-03-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 9-fluorprednisolonderivater NO151043C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2712862A DE2712862C2 (de) 1977-03-21 1977-03-21 Derivate des 9-Fluorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE19782809732 DE2809732C2 (de) 1978-03-03 1978-03-03 Derivate des 9-Fluorprednisolons, Verfahren zu ihrer Herstellung, und pharmazeutische Präparate, die diese Wirkstoffe enthalten

Publications (3)

Publication Number Publication Date
NO780984L true NO780984L (no) 1978-09-22
NO151043B NO151043B (no) 1984-10-22
NO151043C NO151043C (no) 1985-01-30

Family

ID=25771793

Family Applications (1)

Application Number Title Priority Date Filing Date
NO780984A NO151043C (no) 1977-03-21 1978-03-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 9-fluorprednisolonderivater

Country Status (20)

Country Link
JP (1) JPS53130651A (no)
AT (1) AT365203B (no)
AU (1) AU525614B2 (no)
CA (1) CA1104124A (no)
CH (1) CH638226A5 (no)
CS (1) CS202591B2 (no)
DD (1) DD134955A5 (no)
DK (1) DK126378A (no)
ES (1) ES468107A1 (no)
FR (1) FR2384792A1 (no)
GB (1) GB1603281A (no)
GR (1) GR70385B (no)
IE (1) IE46584B1 (no)
IL (1) IL54308A (no)
IT (1) IT1095477B (no)
LU (1) LU79271A1 (no)
NO (1) NO151043C (no)
NZ (1) NZ186735A (no)
RO (1) RO81525B (no)
SE (1) SE431656B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853785A1 (de) * 1978-12-11 1980-06-19 Schering Ag Neue prednison-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung
JPH07116215B2 (ja) * 1989-04-19 1995-12-13 エスエス製薬株式会社 新規なステロイド化合物
JPH07213320A (ja) * 1994-02-04 1995-08-15 Daiwa:Kk 長尺物用バック

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2055221A1 (en) * 1970-11-10 1972-05-18 Laboratorio Chimico Farmaceutico Dr. P. Blasina S.R.L., Mailand (Italien) 17-acyloxy-3-keto-pregn-4-enes prepn - by acylating 17-hydroxy steroids in presence ofstannic chloride
CH529739A (fr) * 1972-02-28 1972-10-31 Sdc Steroidi Dev Co Procédé pour la préparation d'un stéroïde de la série des prégnadiènes
US3832366A (en) * 1973-07-30 1974-08-27 Squibb & Sons Inc Process for preparing 21-chloro-17-acyloxy-20-ketosteroids

Also Published As

Publication number Publication date
FR2384792A1 (fr) 1978-10-20
SE7803168L (sv) 1978-09-22
AT365203B (de) 1981-12-28
GB1603281A (en) 1981-11-25
IL54308A (en) 1984-03-30
DK126378A (da) 1978-09-22
CA1104124A (en) 1981-06-30
JPS53130651A (en) 1978-11-14
RO81525B (ro) 1983-04-30
IL54308A0 (en) 1978-06-15
JPS6131116B2 (no) 1986-07-17
CS202591B2 (en) 1981-01-30
FR2384792B1 (no) 1980-04-04
IT1095477B (it) 1985-08-10
LU79271A1 (de) 1978-06-29
ATA195978A (de) 1981-05-15
IE780545L (en) 1978-09-21
ES468107A1 (es) 1979-07-01
CH638226A5 (en) 1983-09-15
AU3434678A (en) 1979-09-27
NO151043C (no) 1985-01-30
NO151043B (no) 1984-10-22
DD134955A5 (de) 1979-04-04
NZ186735A (en) 1980-10-24
IE46584B1 (en) 1983-07-27
IT7821364A0 (it) 1978-03-20
AU525614B2 (en) 1982-11-18
SE431656B (sv) 1984-02-20
GR70385B (no) 1982-10-05
RO81525A (ro) 1983-04-29

Similar Documents

Publication Publication Date Title
NO781082L (no) Fremgangsmaate ved fremstilling av jodofore forbindelser
NO149174C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme tiazinderivater
SE7808356L (sv) Forfarande for framstellning av liposomer
NO803868L (no) Fremgangsmaate ved fremstilling av nye kinazolinderivater
SE7811689L (sv) Forfarande for framstellning av maytansinoider
NO783442L (no) Fremgangsmaate ved fremstilling av nye fenylethanolaminderivater
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
NO773682L (no) Fremgangsmaate ved fremstilling av furocumariner
NO783143L (no) Fremgangsmaate ved fremstilling av herpesvaksine
NO781168L (no) Fremgangsmaate ved fremstilling av diasepinderivater
NO781678L (no) Fremgangsmaate ved fremstilling av olefiner
NO780777L (no) Fremgangsmaate ved fremstilling av 1-azaxanthon-3-carboxylsyrer
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO803247L (no) R fremgangsmaate ved fremstilling av nye pyridothienotriazine
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
NO783420L (no) Fremgangsmaate ved fremstilling av nye lactamforbindelser
BR7800822A (pt) Process for the preparation of new esters
SE7805676L (sv) Nytt forfarande for framstellning av alkaloider av leurosintypen
NO782411L (no) Fremgangsmaate ved fremstilling av thienopyridinderivater
NO783705L (no) Fremgangsmaate ved fremstilling av quinazolinderivater
NO782464L (no) Fremgangsmaate ved fremstilling av nye angiotensin ii analoger
NO780190L (no) Fremgangsmaate ved fremstilling av urea
NO782242L (no) Fremgangsmaate ved fremstilling av auranofin
NO781391L (no) Fremgangsmaate ved fremstilling av auranofin
NO784235L (no) Fremgangsmaate ved fremstilling av benzazepin-derivater